News

The research ministry and Afssaps, the medicines regulator, in corroboration with 10 other agencies and organisations have formed a scientific interest group to reduce or eliminate unnecessary animal

According to Louis Galambos, professor of economic and business history at the Johns Hopkins University in the US, the increasing drug development costs coupled with the governmental pressures

Data from preclinical studies and from the company’s Retime 1.0 study demonstrated that cardiac electric tomography (CET) quantifies important aspects of cardiac performance using an automated, operator-independent technique

Terms of the termination include a repayment of the initial $2.6 million license fee originally paid to Scient’x and a full repayment of inventory that Alphatec will return

The trial includes 1,820 patients and examines the potential benefits of Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) in a new population of heart failure patients. It is

R7128, a prodrug of PSI-6130, is a nucleoside analogue polymerase inhibitor of hepatitis c virus (HCV) that is being developed through Pharmasset’s collaboration with Roche. Cohort 3 will

RotaTeq is a live, oral pentavalent vaccine indicated for the prevention of rotavirus gastroenteritis. Pablo Legorreta, CEO of Royalty Pharma, said: “With the addition of this royalty on

In clinical studies, Relistor significantly decreased the constipating effects of opioids without interfering with pain relief. Wyeth expects to make Relistor available in the US in early June,

The contract calls for Pharmavite’s exclusive rights to Reducol in the US mass-market distribution channel. Pharmavite is expected to support the CholestOff and CholestOff Complete brands through various